DRMAW Dermata Therapeutics, Inc. - Warrant
$0,00
Precio · Ago 17, 2026
Fundamentales a fecha de Ago 11, 2026
Rango 52S
$0–$0
1% of range
Calificación del Analista
—
Precio Objetivo
—
P/E (TTM)
—
ROE
-127.7%
Margen de Beneficio Neto
—
DRMAW Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.00
Capitalización Bursátil
—
P/E (TTM)
—
BPA (TTM)
$-8.16
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-127.7%
Deuda/Capital
—
Rango 52S
$0 – $0
DRMAW Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-8.16
2023-12-31
→
2025-12-31
Flujo de caja libre
—
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
DRMAW
Mediana de Pares
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
DRMAW
Mediana de Pares
ROA
-132.6%
—
ROE
-127.7%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
DRMAW
Mediana de Pares
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
DRMAW
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
DRMAW
Mediana de Pares
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $8M | $4M | $6M | $3M | $2M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $4M | $2M | |
| Operating Expenses | $8M | $13M | $8M | $10M | · | · | |
| Operating Income | $-8M | $-13M | $-8M | $-10M | $-8M | $-3M | |
| Interest Expense | · | · | · | · | $45.6K | $197.3K | |
| Interest Income | $215.0K | $225.8K | · | · | · | · | |
| Income Tax | · | · | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-12M | $-8M | $-10M | $-8M | $-3M | |
| EPS (Basic) | $-8.16 | $-80.32 | $-39.99 | $-13.92 | $-2.43 | $-1.69 | |
| EPS (Diluted) | $-8.16 | $-80.32 | $-39.99 | · | · | · | |
| Shares (Basic) | 926,192 | 152,974 | · | · | 4,302,232 | 1,911,009 | |
| Shares (Diluted) | 926,192 | 152,974 | 194,928 | · | · | · | |
| EBITDA | $-8M | $-13M | $-8M | · | $-8M | · |
Balance general 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $3M | · | $6M | $11M | $530.4K | |
| Prepaid Expense | $341.8K | $372.3K | $540.5K | $703.2K | $825.1K | $75.1K | |
| Current Assets | $8M | · | · | · | $12M | $605.5K | |
| PP&E (Net) | · | · | · | · | $0 | $0 | |
| Total Assets | $8M | $4M | $8M | $7M | $12M | $605.5K | |
| Accounts Payable | $460.8K | $808.0K | $866.0K | $496.7K | $515.2K | $104.3K | |
| Current Liabilities | · | · | · | · | $2M | $4M | |
| Total Liabilities | $2M | $2M | $2M | $922.6K | $2M | $4M | |
| Total Debt | · | · | · | · | $0 | · | |
| Common Stock | $266 | $25 | $26 | $77 | $833 | $0 | |
| Paid-in Capital | $79M | $67M | $60M | $52M | $46M | $0 | |
| Retained Earnings | $-73M | $-66M | $-53M | $-46M | $-36M | $-28M | |
| Stockholders' Equity | $6M | $2M | $6M | $6M | $10M | $-3M | |
| Liabilities + Equity | $8M | $4M | $8M | $7M | $12M | $605.5K | |
| Shares Outstanding | 2,660,110 | 251,725 | 261,998 | 770,115 | 8,328,629 | · |
Flujo de Efectivo 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $0 | $322 | |
| Stock-based Comp | $143.7K | $657.6K | $522.1K | $930.3K | $2M | $0 | |
| Operating Cash Flow | $-8M | $-11M | $-6M | $-9M | $-6M | $-4M | |
| Stock Issued | $12M | $7M | $8M | $4M | $15M | · | |
| Net Stock Activity | $12M | $7M | $8M | · | · | · | |
| Financing Cash Flow | $12M | $7M | $8M | $4M | $16M | $3M | |
| Net Change in Cash | $4M | $-4M | · | · | $10M | $-1M |
Rentabilidad 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -132.6% | -213.5% | -104.5% | · | -129.2% | · | |
| ROE | -127.7% | -389.9% | -122.2% | · | -69.9% | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 7.7 | · | |
| Quick Ratio | · | · | · | · | 7.1 | · | |
| Debt / Equity | · | · | · | · | 0.0 | · | |
| Interest Coverage | · | · | · | · | -172.3 | · |
Valoración (TTM) 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $182.8K | $182.8K | $182.8K | $63.6K | $-45.6K | · | |
| Net Income TTM | $-8M | $-12M | $-8M | $-10M | $-8M | · |
Estado de resultados 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $212.6K | $383.7K | $526.6K | $504.4K | $617.8K | $1M | $2M | $2M | $2M | $2M | $1M | $903.0K | $838.9K | $1M | $889.4K | $2M | |
| SG&A Expense | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $824.3K | $874.6K | $2M | $1M | $909.0K | $893.5K | $1M | $822.3K | $892.8K | |
| Operating Expenses | $3M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | |
| Interest Income | $46.5K | $78.7K | $38.5K | $68.7K | $71.6K | $36.2K | $49.4K | $52.5K | $54.6K | $69.3K | · | · | · | · | · | · | |
| Net Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | |
| EPS (Basic) | $-0.74 | $-0.48 | $-4.40 | $-1.65 | $-1.22 | $-4.47 | $-11.03 | $-20.41 | $-41.82 | $-7.06 | $-36.55 | $-0.54 | $-0.63 | $-2.27 | $-6.53 | $-3.16 | |
| EPS (Diluted) | $-0.74 | $-0.48 | $-4.40 | $-1.65 | $-1.66 | $-4.47 | $-11.03 | $-20.41 | $-41.82 | $-7.06 | · | · | · | · | · | · | |
| Shares (Basic) | 4,022,143 | 3,858,921 | -6,281,469 | 1,026,457 | 1,026,506 | 515,465 | -514,143 | 155,465 | 67,654 | 443,998 | · | · | · | · | · | · | |
| Shares (Diluted) | 4,022,143 | 3,858,921 | -6,281,469 | 1,026,457 | 1,026,506 | 515,465 | -514,143 | 155,465 | 67,654 | 443,998 | · | · | · | · | · | · | |
| EBITDA | $-3M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M | $-3M | $-3M | · | $-2M | $-2M | $-2M | · | $-2M |
Balance general 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $7M | $8M | $5M | $6M | $10M | $3M | · | · | · | · | $7M | $8M | $9M | · | $8M | |
| Inventory | $149.7K | $93.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $593.6K | $427.3K | $341.8K | $407.3K | $159.6K | $285.7K | $372.3K | $543.6K | $289.5K | $446.1K | $540.5K | $691.9K | $274.4K | $528.3K | $703.2K | $908.1K | |
| Current Assets | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| PP&E (Net) | $129.4K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $5M | $7M | $8M | $5M | $7M | $10M | $4M | $7M | $5M | $5M | $8M | $7M | $9M | $9M | $7M | $9M | |
| Accounts Payable | $1M | $318.3K | $460.8K | $453.4K | $413.7K | $1M | $808.0K | $863.6K | $1M | $822.5K | $866.0K | $474.5K | $437.8K | $492.9K | $496.7K | $483.7K | |
| Total Liabilities | $2M | $1M | $2M | $1M | $1M | $3M | $2M | $2M | $2M | $1M | $2M | $916.8K | $682.9K | $1M | $922.6K | $2M | |
| Common Stock | $402 | $402 | $266 | $84 | $64 | $603 | $25 | $168 | $69 | $666 | $26 | $319 | $319 | $239 | $77 | $1.2K | |
| Paid-in Capital | $82M | $81M | $79M | $75M | $75M | $75M | $67M | $67M | $63M | $60M | $60M | $58M | $58M | $56M | $52M | $51M | |
| Retained Earnings | $-78M | $-75M | $-73M | $-71M | $-70M | $-68M | $-66M | $-63M | $-59M | $-57M | $-53M | $-51M | $-50M | $-48M | $-46M | $-44M | |
| Stockholders' Equity | $3M | $6M | $6M | $4M | $6M | $7M | $2M | $5M | $3M | $4M | $6M | $6M | $8M | $8M | $6M | $7M | |
| Liabilities + Equity | $5M | $7M | $8M | $5M | $7M | $10M | $4M | $7M | $5M | $5M | $8M | $7M | $9M | $9M | $7M | $9M | |
| Shares Outstanding | 4,022,143 | 4,022,143 | 2,660,110 | 844,457 | 637,757 | 6,032,648 | 251,725 | 1,677,768 | 693,175 | 6,660,840 | 261,998 | 3,189,034 | 3,189,034 | 2,388,157 | 770,115 | 12,102,214 |
Flujo de Efectivo 6
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41.8K | $43.3K | $29.5K | $37.8K | $39.2K | $37.2K | $29.8K | $21.0K | $19.6K | $587.2K | $128.5K | $131.2K | $131.2K | $131.3K | $220.9K | $235.0K | |
| Operating Cash Flow | $-2M | $-2M | $-1M | $-2M | $-3M | $-2M | $-3M | $-3M | $-2M | $-3M | $-1M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| Stock Issued | · | · | $4M | $-12.6K | $-547.9K | $9M | $-69.5K | $5M | $2M | · | $2M | $-35.4K | $2M | $4M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $9M | · | · | · | $0 | · | · | · | $4M | · | · | |
| Financing Cash Flow | $-323 | $2M | $4M | $-13.0K | $-547.9K | $8M | $-68.6K | $5M | $2M | · | $2M | $-35.4K | $2M | $4M | $0 | $200 | |
| Net Change in Cash | $-3M | $-576.7K | $3M | $-2M | $-3M | $7M | $-3M | $1M | $213.4K | $-3M | · | · | · | · | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -1953.3% | -5579.4% | -6067.3% | · | 11384.5% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | -1853.3% | -5479.4% | -5967.3% | · | 11284.5% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | -1953.3% | -5579.4% | -6067.3% | · | 11384.5% | |
| ROA | -49.6% | -21.1% | · | -28.8% | -28.6% | -30.3% | · | -45.3% | -40.6% | -43.3% | · | -21.1% | -17.2% | -24.4% | · | -21.4% | |
| ROE | -65.2% | -27.0% | · | -38.9% | -38.1% | -41.5% | · | -56.9% | -49.9% | -52.7% | · | -24.8% | -19.2% | -28.1% | · | -24.3% |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | -0.0 |
Valoración (TTM) 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $182.8K | $182.8K | · | $182.8K | $182.8K | $182.8K | · | $182.8K | $182.8K | $182.8K | · | $182.8K | $90.1K | $59.0K | · | $22.1K | |
| Net Income TTM | $-8M | $-8M | · | $-9M | $-10M | $-11M | · | $-11M | $-9M | $-9M | · | $-8M | $-9M | $-10M | · | $-10M | |
| Market Cap | $73.6K | $73.6K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.4 | 0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -24754.1% | -45136.6% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Beneficio neto | $-8M | $-12M | $-8M | $-10M | $-8M |
| EPS Diluido | $-8.16 | $-80.32 | $-39.99 | — | — |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | — | — | — | — | 0.0 |
| Ratio corriente | — | — | — | — | 7.7 |
| Ratio Rápido | — | — | — | — | 7.1 |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 3 declarantes · $15K total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 1 (0 vs trimestre anterior) | 0 (-1 vs trimestre anterior) | 1 (+1 vs trimestre anterior) | 0 (0 vs trimestre anterior) | +12K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | $15 480 | 12 000 | 99,88% | Acciones |
| UBS Group AG | $18 | 1 804 | 0,12% | Acciones |
| Virtu Financial LLC | $0 | 11 029 | 0,00% | Acciones |
Informantes de la empresa 3 insiders · 2 directivos · 2 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| PROEHL GERALD T | PRESIDENT, CHAIRMAN, CEO | 16 de agosto de 2026 A | 292 631 | 0 | 0 | $0 |
| Kyri K. Van Hoose | SVP, CFO | 16 de agosto de 2026 A | 232 463 | 0 | 0 | $0 |
| Kathleen D. Scott | Consejero | 16 de junio de 2026 S | 0 | 0 | 1 | $-13 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto